Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Companion Protocol for ¹³C-Methacetin Breath Test in Emricasan Phase 2 Study
NCT03462576Terminated
- Sponsor
- Meridian Bioscience
- Start
- Jun 2017
- Primary completion
- Jul 2019
- Countries
- 1
01
Overview
Randomised, double-blind trial (3 arms), sponsored by Meridian Bioscience. Primary endpoint: Number of Subjects Experiencing a High Risk Event Based on a 5.5%/Hour Cut-off at 1 hour. Started Jun 2017; status: terminated.
Beyond the preview
Go deeper on NCT03462576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03462576.